IMMNOV (IMMNOV) News
Follow IMMNOV (IMMNOV) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Immunovia Rights Issue Targets SEK 63.4M, 78.8% Covered
Immunovia's prospectus for a rights issue of approximately SEK 63.4 million was approved and registered. The issue is covered to approximately 78.8%; full subscription would raise approximately SEK 63.4 million before co
EQUITY | Nov 04, 2026, 01:00 PM UTC
M
Immunovia Sets Terms for Rights Issue of Up to SEK 63.4M
The issue is priced at SEK 0.06 per unit, comprising two shares and one warrant. Full subscription implies about 75.9% dilution; an extraordinary general meeting must approve the issue. Warrant exercise could raise up to
EQUITY | Oct 28, 2026, 07:01 PM UTC
L
Immunovia (IMMNOV) Launches Partly Guaranteed SEK 63M Rights Issue
Immunovia announced a partly guaranteed rights issue of units of about SEK 63M, with subscription set for 9—23 Nov 2026. Carlsquare paused its research coverage until completion.Material DetailsContext by AI AnalystThis
NEWS | Sep 29, 2026, 07:52 AM UTC
L
Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Immunovia AB OMXSTO:IMMNOV:Source text:Further company coverage
NEWS | Sep 29, 2026, 05:54 AM UTC
L
Immunovia (IMMNOV) Calls EGM to Approve Dilutive Rights Issue
Immunovia AB (publ) will hold an EGM on Oct 29, 2026 to approve a rights issue of units (2 shares + 1 warrant TO 4) and amend Articles to raise capital/share limits. Record date Nov 5; subscription Nov 9—23; TO 4 exercis
EQUITY | Sep 28, 2026, 04:35 PM UTC
L
Immunovia AB (publ) (IMMNOV) Plans SEK 63M Rights Issue, 80% Covered
Immunovia will conduct a SEK 63M rights issue of units, subject to EGM approval, with ~SEK 50M (≈80%) covered by undertakings and a bottom guarantee. Proceeds will fund US commercialization of PancreaSure, clinical studi
NEWS | Sep 28, 2026, 04:31 PM UTC
L
Immunovia AB (IMMNOV) Files for Medicare LCD Coverage of PancreaSure
Immunovia AB submitted a formal request for a new Local Coverage Determination for PancreaSure, seeking Medicare coverage for its blood test for early detection of pancreatic cancer in high—risk individuals.Material Deta
NEWS | Sep 28, 2026, 12:01 PM UTC